PARATEK PHARMACEUTICALS INC
BOSTON, MA · CIK 0001037643 · Biotech · Acquired
Tetracycline-class antibiotics and novel antimicrobial therapeutics
paratekpharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $93M
- 1 Form D · Jul 2014
- 147 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 7 granted · 33 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $93,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2209 | ARIETIS CORPORATION | — | — |
| 2210 | MBX Biosciences | — | $95M |
| 2211 | TECTARIA BIO LLC | — | — |
| 2212 | PARATEK PHARMACEUTICALS INC | — | $93M |
| 2213 | Milestone Pharmaceuticals Inc. | — | $91M |
| 2214 | BE COOL PHARMACEUTICS, LLC | — | — |
| 2215 | Xeris Pharmaceuticals, Inc. | — | $80M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Beverly ArmstrongExecutive Officer
- Michael BighamDirector · Executive Officer
- Kathryn BoxmeyerExecutive Officer
- Sean JohnstonExecutive Officer
- Richard LimDirector
- Evan LohDirector · Executive Officer
- Dennis MolnarExecutive Officer
- S. TanakaExecutive Officer
Patents
- Methods For Synthesizing And Purifying Aminoalkyl Tetracycline Compoundsapplication
- Salts And Polymorphs Of A Tetracycline Compoundapplication
- Substituted Tetracycline Compounds For Treatment Of Inflammatory Skin Disordersapplication
- Substituted Tetracycline Compoundsapplication
- Oral And Injectable Formulations Of Tetracycline Compoundsapplication
- Minocycline Compounds For Biodefenseapplication
- Methods For Synthesizing Substituted Tetracycline Compoundsapplication
- 9-AMINOMETHYL Minocycline Compounds And Uses Thereofapplication
- Minocycline Compounds And Methods Of Use Thereofapplication
- 9-AMINOMETHYL Minocycline Compounds And Use Thereof In Treating Community-acquired Bacterial Pneumonia (cabp)application
- Methods For Treating And Preventing C. Difficile Infectionapplication
- Minocycline Compounds For Biodefenseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.